Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Jenkins

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2024
Patterns of TB transmission in the United States, 2011-2017K Yamkovoy, J L Self, H E Jenkins, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in MoldovaH E Jenkins, A Ciobanu, V Plesca, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 11, 2025
Xpert MTB/RIF Ultra 'trace': considerations for diagnosticsL E Scott, M P da Silva, P Marokane, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 1, 2014
Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011H E Jenkins, M Gegia, J Furin, et al.
IJTLD Open|March 17, 2025
The risk of rifampicin-resistant TB after drug-susceptible TB treatmentA N Shapiro, H Moultrie, K R Jacobson, et al.
IJTLD Open|June 17, 2026
Scoping review of community-wide screening to break the chain of TB transmissionC R Horsburgh, H E Jenkins, E A Kendall, et al.
IJTLD Open|July 18, 2024
The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020A N Shapiro, M Dolynska, S S Chiang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 23, 2023
Survival of people with untreated TB: effects of time, geography and settingC A Rodriguez, S V Leavitt, T C Bouton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2024
Outcomes for people with TB by disease severity at presentationS V Leavitt, C A Rodriguez, T C Bouton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2024
Risk factors for and timing of presumptive recurrent TBA N Shapiro, L Scott, H Moultrie, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2024
Patterns of TB transmission in the United States, 2011-2017K Yamkovoy, J L Self, H E Jenkins, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 15, 2013
Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in MoldovaH E Jenkins, A Ciobanu, V Plesca, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 11, 2025
Xpert MTB/RIF Ultra 'trace': considerations for diagnosticsL E Scott, M P da Silva, P Marokane, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 1, 2014
Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011H E Jenkins, M Gegia, J Furin, et al.
IJTLD Open|March 17, 2025
The risk of rifampicin-resistant TB after drug-susceptible TB treatmentA N Shapiro, H Moultrie, K R Jacobson, et al.
IJTLD Open|June 17, 2026
Scoping review of community-wide screening to break the chain of TB transmissionC R Horsburgh, H E Jenkins, E A Kendall, et al.
IJTLD Open|July 18, 2024
The impact of the COVID-19 pandemic on TB notifications in Ukraine in 2020A N Shapiro, M Dolynska, S S Chiang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 23, 2023
Survival of people with untreated TB: effects of time, geography and settingC A Rodriguez, S V Leavitt, T C Bouton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 7, 2024
Outcomes for people with TB by disease severity at presentationS V Leavitt, C A Rodriguez, T C Bouton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 29, 2024
Risk factors for and timing of presumptive recurrent TBA N Shapiro, L Scott, H Moultrie, et al.
Pageof 3